Sunzen Biotech Valuation
| 0148 Stock | 0.32 0.00 0.00% |
Sunzen Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Sunzen Biotech Bhd from inspecting the company fundamentals such as EBITDA of 6.57 M, price to sales of 1.34 X, and Return On Equity of 2.91 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sunzen Biotech's price fluctuation is extremely dangerous at this time. Calculation of the real value of Sunzen Biotech Bhd is based on 3 months time horizon. Increasing Sunzen Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sunzen stock is determined by what a typical buyer is willing to pay for full or partial control of Sunzen Biotech Bhd. Since Sunzen Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sunzen Stock. However, Sunzen Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.28 | Hype 0.32 | Naive 0.32 |
The intrinsic value of Sunzen Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Sunzen Biotech's stock price.
Estimating the potential upside or downside of Sunzen Biotech Bhd helps investors to forecast how Sunzen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sunzen Biotech more accurately as focusing exclusively on Sunzen Biotech's fundamentals will not take into account other important factors: Sunzen Biotech Total Value Analysis
Sunzen Biotech Bhd is presently forecasted to have takeover price of 128.73 M with market capitalization of 147.73 M, debt of 5.08 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sunzen Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
128.73 M | 147.73 M | 5.08 M |
Sunzen Biotech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Sunzen suggests not a very effective usage of assets in November.Sunzen Biotech Profitability Analysis
The company reported the revenue of 90.48 M. Net Income was 3.71 M with profit before overhead, payroll, taxes, and interest of 0.About Sunzen Biotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Sunzen Biotech Bhd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sunzen Biotech Bhd based exclusively on its fundamental and basic technical indicators. By analyzing Sunzen Biotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Sunzen Biotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sunzen Biotech. We calculate exposure to Sunzen Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sunzen Biotech's related companies.8 Steps to conduct Sunzen Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sunzen Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sunzen Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sunzen Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sunzen Biotech's revenue streams: Identify Sunzen Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sunzen Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sunzen Biotech's growth potential: Evaluate Sunzen Biotech's management, business model, and growth potential.
- Determine Sunzen Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sunzen Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Sunzen Stock
Sunzen Biotech financial ratios help investors to determine whether Sunzen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunzen with respect to the benefits of owning Sunzen Biotech security.